These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23263713)

  • 1. [New developments in hereditary blistering skin diseases].
    Bruckner-Tuderman L
    Hautarzt; 2013 Jan; 64(1):7-11. PubMed ID: 23263713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of inherited skin-blistering disorders, and therapeutic implications.
    Aumailley M; Has C; Tunggal L; Bruckner-Tuderman L
    Expert Rev Mol Med; 2006 Oct; 8(24):1-21. PubMed ID: 17040578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary blistering disorders].
    Has C; Kern JS; Bruckner-Tuderman L
    Hautarzt; 2004 Oct; 55(10):920, 922-30. PubMed ID: 15340710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The many facets of inherited skin fragility].
    Has C; Kiritsi D
    Hautarzt; 2014 Jun; 65(6):490-8. PubMed ID: 24898503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermolysis bullosa : Diagnosis and therapy].
    Has C; Bruckner-Tuderman L
    Hautarzt; 2011 Feb; 62(2):82-90. PubMed ID: 21271234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin Barrier and Autoimmunity-Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin.
    Stevens NE; Cowin AJ; Kopecki Z
    Front Immunol; 2019; 10():1089. PubMed ID: 31156638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies*.
    Uitto J
    Acta Derm Venereol; 2009; 89(3):228-35. PubMed ID: 19479117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of skin fragility.
    Has C; Bruckner-Tuderman L
    Annu Rev Genomics Hum Genet; 2014; 15():245-68. PubMed ID: 24898041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Orogenital and conjunctival involvement in hereditary and autoimmune blistering diseases].
    Laimer M; Lanschützer CM; Emberger M; Nischler E; Stoiber J; Hintner H
    Hautarzt; 2009 Nov; 60(11):881-90. PubMed ID: 19855943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do keratinizing disorders and blistering disorders overlap?
    Hamada T; Tsuruta D; Fukuda S; Ishii N; Teye K; Numata S; Dainichi T; Karashima T; Ohata C; Furumura M; Hashimoto T
    Exp Dermatol; 2013 Feb; 22(2):83-7. PubMed ID: 23039137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited epidermolysis bullosa: update on the clinical and genetic aspects.
    Mariath LM; Santin JT; Schuler-Faccini L; Kiszewski AE
    An Bras Dermatol; 2020; 95(5):551-569. PubMed ID: 32732072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular therapies for heritable blistering diseases.
    Tamai K; Kaneda Y; Uitto J
    Trends Mol Med; 2009 Jul; 15(7):285-92. PubMed ID: 19581127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer Treatment Modalities in Epidermolysis Bullosa.
    Bruckner-Tuderman L
    Indian Dermatol Online J; 2019; 10(3):244-250. PubMed ID: 31149565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's new in blistering disorders?
    Chaudhari P; Marinkovich MP
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):255-63. PubMed ID: 17547846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dermo-epidermal juncture. Recent aspects of pathophysiology].
    Bruckner-Tuderman L
    Hautarzt; 1993 Jan; 44(1):1-4. PubMed ID: 8436501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa.
    Alexeev V; Donahue A; Uitto J; Igoucheva O
    Stem Cell Res Ther; 2016 Aug; 7(1):124. PubMed ID: 27568180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and diagnostic aspects of genetic skin fragility.
    Has C; Bruckner-Tuderman L
    J Dermatol Sci; 2006 Dec; 44(3):129-44. PubMed ID: 16996720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse.
    Spirito F; Charlesworth A; Linder K; Ortonne JP; Baird J; Meneguzzi G
    J Invest Dermatol; 2002 Sep; 119(3):684-91. PubMed ID: 12230513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital blistering.
    Nielsen-Scott A; Goodyear H
    BMJ; 2019 Oct; 367():l5287. PubMed ID: 31575524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.